Ang Zheng

5PUBLICATIONS
4CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cross-sectional analysis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Mar 17, 2025
Lnc-TPT1-AS1/CBP/ATIC Axis Mediated Purine Metabolism Activation Promotes Breast Cancer Progression.

Yiyun Zhang, Hanyu Zhang, Mingcui Li

|Aug 21, 2024
SNORA5A regulates tumor-associated macrophage M1/M2 phenotypes via TRAF3IP3 in breast cancer.

Yiqi Zhang, Ang Zheng, Yue Shi

|Jun 07, 2023
Adjuvant and neoadjuvant therapy with cyclin-dependent kinase 4 and 6 inhibitors in hormone receptor-positive, human epidermal growth factor receptor 2-negative early breast cancer: a systematic review and meta-analysis.

Meilin Zhang, Jian Song, Shigang Guo

|May 10, 2019
Oncotype DX for Comprehensive Treatment in Male Breast Cancer: A Case Report and Literature Review.

Ang Zheng, Lin Zhang, Ziyao Ji

|Jun 21, 2018
How great is current curative expenditure and catastrophic health expenditure among patients with cancer in China? A research based on "System of Health Account 2011".

Ang Zheng, Wenjuan Duan, Lin Zhang

Pageof 1

Frequent Collaborators

1 joint publications

Yiqi Zhang

1 joint publications

Yue Shi

1 joint publications

Heng Lu

1 joint publications

Fei Ma